Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · IEX Real-Time Price · USD
0.870
-0.230 (-20.91%)
At close: Jun 24, 2022 4:00 PM
1.020
+0.150 (17.241%)
After-hours:
Jun 24, 2022 7:59 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
|
Selling, General & Admin
|
9.52 | 11.93 | 10.88 | 10.64 | 10.22 | 7.62 | 2.42 | 0.12 |
|
Research & Development
|
29.12 | 31.83 | 37.98 | 38.59 | 46.31 | 29.36 | 11.35 | 0.04 |
|
Operating Expenses
|
38.63 | 43.76 | 48.85 | 49.22 | 56.52 | 36.98 | 13.77 | 0.16 |
|
Operating Income
|
-38.63 | -43.76 | -48.85 | -49.22 | -56.52 | -36.98 | -13.77 | -0.16 |
|
Other Expense / Income
|
4.61 | -37.77 | -2.18 | -2.28 | -0.86 | -0.6 | 17.57 | 0 |
|
Pretax Income
|
-43.24 | -6 | -46.67 | -46.94 | -55.66 | -36.38 | -31.34 | -0.16 |
|
Net Income
|
-43.24 | -6 | -46.67 | -46.94 | -55.66 | -36.38 | -31.34 | -0.16 |
|
Net Income Common
|
-43.24 | -6 | -46.67 | -46.94 | -55.66 | -36.38 | -31.34 | -0.16 |
|
Shares Outstanding (Basic)
|
42 | 29 | 29 | 28 | 20 | 15 | 0 | 0 |
|
Shares Outstanding (Diluted)
|
42 | 29 | 29 | 28 | 20 | 15 | 0 | 0 |
|
Shares Change
|
41.98% | 0.44% | 6.69% | 34.27% | 32.85% | 4027.48% | 119.43% | - |
|
EPS (Basic)
|
-1.03 | -0.20 | -1.59 | -1.71 | -2.72 | -2.36 | -83.86 | -0.95 |
|
EPS (Diluted)
|
-1.03 | -0.20 | -1.59 | -1.71 | -2.72 | -2.36 | -83.86 | -0.95 |
|
Free Cash Flow Per Share
|
-0.88 | -1.18 | -1.27 | -1.50 | -2.27 | -1.95 | -34.99 | -0.56 |
|
EBITDA
|
-42.78 | -5.36 | -45.93 | -46.09 | -54.82 | -35.78 | -31.19 | -0.16 |
|
Depreciation & Amortization
|
0.46 | 0.63 | 0.74 | 0.85 | 0.84 | 0.59 | 0.15 | 0 |
|
EBIT
|
-43.24 | -6 | -46.67 | -46.94 | -55.66 | -36.38 | -31.34 | -0.16 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).